As AGBT Precision Health enters our 7th year, we continue to focus on technologies, implementation, and major research breakthroughs.
Over the last several years, this meeting has highlighted the most provocative discoveries and major initiatives in genomic medicine from leaders of national healthcare systems, genomics institutes, international biobank initiatives, transformative diagnostic approaches, and hospital-based implementation and reimbursement.
Continuing the historical focus of AGBT on technologies and public-private partnerships, the Precision Health Meeting highlights innovative technologies and their impact on clinical diagnostics and therapeutic development, as well as the evolving view of genotype-phenotype interpretation from rare variants to polygenic risk scores.
Cambridge Consultants Symon Cotton, head of life sciences for global medical technology will be presenting on 'Sequencing 2030 - the challenges and opportunities'
Key Note: Sequencing 2030 - the challenges and opportunities
Date | 11 September 2022
Time | TBC
Location | TBC
Speaker | Dr Symon Cotton, head of life sciences
Speaker Bio | Dr Symon Cotton heads-up the life science business at Cambridge Consultants and has a background in Physics and Computer Science, gaining a PhD in computational medical physics at Birmingham University, UK. He has founded a number of start-up companies bringing novel medical diagnostics to market and now works with numerous companies to develop innovative medical devices.